Introduction {#s1}
============

Spinal cord injury (SCI) results in impairment of motor, sensory, and autonomic systems, causing profound deregulation of almost every bodily function. The failure of large-scale clinical trials of drug therapies in acute SCI ([@bib5]; [@bib34]), and the lack of success in translating preclinical therapies to humans ([@bib74]), leaves clinicians without effective treatment options for SCI. As such, hemodynamic management and surgical decompression remain the only options to influence neurological outcomes immediately following acute SCI, typically with only marginal improvements ([@bib39]; [@bib84]; [@bib29]). The absence of an effective treatment for SCI reflects the complexity of the pathophysiologic mechanisms activated by central nervous system (CNS) injury. The additive effects of the immune response ([@bib49]; [@bib19]), multiple forms of cell death ([@bib80]; [@bib13]), neuronal growth suppression ([@bib36]; [@bib76]), and the formation of an inhibitory glial scar ([@bib6]) pose a challenge to the development of new therapeutic strategies.

A major obstacle to the development of targeted therapies for SCI is the fragmentary state of our understanding of SCI pathophysiology. The response to trauma within the human spinal cord is mediated by multiple coordinated molecular pathways, yet these processes are rarely studied in an integrated manner. An additional challenge in translation of novel therapies is the reliance of clinical trials on standardized neurological assessments for patient enrolment and stratification ([@bib28]). These measures are highly variable, operator-dependent, and may be impossible to perform in many SCI patients ([@bib52]). Systems biology approaches provide powerful means to elucidate the coordinated molecular processes underlying the pathophysiology of complex diseases ([@bib86]; [@bib69]; [@bib91]; [@bib48]). In particular, gene coexpression network analysis can complement reductionist descriptions of isolated gene functions by identifying networks of genes responsible for driving disease processes ([@bib92]; [@bib70]). Systems-level analyses may additionally have the potential to suggest novel biomarkers capable of stratifying injury severity and predicting functional recovery, and consequently to facilitate the translation of new therapies for acute SCI.

In the present study, we describe an integrated systems biology approach to study the pathophysiology of SCI. We systematically survey decades of biomedical literature in order to establish the complete set of genes implicated in the response to SCI by small-scale experiments. We then integrate this literature-curated gene set with unbiased gene expression data from the human spinal cord. We use weighted gene coexpression network analysis (WGCNA) to establish the normal biological processes within the healthy human spinal cord, and conduct a meta-analysis of publicly available gene expression data to define the gene regulatory network signature of the coordinated physiological response to SCI. We validate our findings at the transcriptomic and proteomic levels, and leverage the resulting systems-level understanding of SCI pathophysiology to define candidate biomarkers for stratification of injury severity and prediction of functional recovery.

Results {#s2}
=======

Systematic literature analysis identifies genes associated with response to SCI {#s2-1}
-------------------------------------------------------------------------------

Despite decades of study, an integrated understanding of the pathophysiological response to SCI remains elusive. This gap represents a central challenge to the development of targeted therapies for SCI. We hypothesized that such an integrated understanding could be achieved by integrating the vast corpus of SCI literature, collected by small-scale experimentation over several decades, within an unbiased, genome-wide framework. An overview of our experimental design is shown in [Figure 1](#fig1){ref-type="fig"}.

![Schematic overview of systems biology approach to SCI pathophysiology integrating small-scale experiments with high-throughput data.\
Systematic analysis of over 500 manuscripts revealed the complete set of genes implicated in SCI pathophysiology by small-scale experiments. SCI genes were integrated with unbiased, genome-wide gene expression data from healthy human spinal cord to identify coexpressed gene subnetworks enriched for known SCI genes. Meta-analysis of SCI gene expression data revealed consensus patterns of subnetwork differential expression after SCI. The resulting consensus network signature of the response to SCI in human spinal cord was subjected to functional enrichment and cell type analyses, validated at the transcriptomic and proteomic levels, and leveraged to nominate quantitative biomarkers of SCI severity.](elife-39188-fig1){#fig1}

As a first step, we sought to systematically establish the complete set of genes implicated in the physiological response to SCI. We conducted a systematic analysis of the SCI literature, reviewing over 500 papers, in order to reveal a set of 695 unique human genes associated with the response to SCI by small-scale experiments ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). Of these genes, 559 were upregulated following SCI, 213 were downregulated, and the protein products of 8 were differentially phosphorylated. Among all genes, 151 were associated with the response to SCI by more than one study ([Figure 2A](#fig2){ref-type="fig"}). The complete set includes genes that have been associated with SCI in a wide range of experimental models of SCI, in addition to human injuries ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}); in multiple species, including human as well as rat, mouse, and rabbit ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}); using a range of experimental techniques ([Figure 2B](#fig2){ref-type="fig"}); and at a variety of time points, from 1 hr to 6 months post-injury ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}).

![Literature curation and validation of genes implicated in the physiological response to SCI by small-scale experiments.\
(**A**) Number of small-scale studies implicating each gene in SCI pathophysiology in the LC gene set. (**B**) Experimental techniques used to associate LC genes with response to SCI in the LC gene set. (**C**) Enrichment for shared Gene Ontology terms among LC genes (all p \< 10^−15^). BP, biological process; CC, cellular component; MF, molecular function. (**D**) Number of protein-protein interactions (PPIs) between LC genes observed in the high-confidence human interactome ([@bib66]) (dotted line) and 1000 randomized interactome networks (density), revealing significant enrichment for PPIs between LC genes relative to random expectation (p \< 10^−3^). (**E**) Size of the largest connected component (LCC) between LC genes in the high-confidence human interactome (dotted line) and 1000 randomized interactome networks (density), revealing LC genes occupy a distinct region of the human interactome (p \< 10^−3^). (**F**) LC genes are prioritized by a disease gene prediction algorithm ([@bib35]) (p \< 10^−15^, Kolmogorov--Smirnov test).](elife-39188-fig2){#fig2}

Validation of literature-curated SCI genes {#s2-2}
------------------------------------------

We validated the biological relevance of our literature-curated (LC) SCI gene set using multiple lines of evidence. First, we established that LC genes were more likely to share common biological functions than random sets of genes, using annotations from the Gene Ontology ([@bib4]). Because functional annotations may be specific or broad, we confirmed that the enrichment held regardless of the number of genes to which each term was annotated ([Figure 2C](#fig2){ref-type="fig"}). Next, we investigated the tendency for the protein products of LC genes to physically interact. Significant enrichment for protein-protein interactions (PPIs) between LC genes was observed relative to random expectation ([Figure 2D](#fig2){ref-type="fig"}, empirical p \< 10^−3^), and we reproduced this finding in multiple independent PPI databases (all p \< 10^−3^, [Figure 2---figure supplement 2A--C](#fig2s2){ref-type="fig"}). Genes implicated in a variety of complex diseases by genome-wide association studies (GWAS) have been found to form distinct modules of densely interacting proteins within the human interactome ([@bib35]). We therefore evaluated whether this same principle held for SCI by calculating the size of the largest connected component (LCC) between LC genes, and found that LC genes collectively formed a significantly larger subnetwork than random expectation ([Figure 2E](#fig2){ref-type="fig"}, empirical p \< 10^−3^), a finding that was again reproduced in independent interaction datasets (p \< 10^−3^, [Figure 2---figure supplement 2D--F](#fig2s2){ref-type="fig"}). Literature-curated genes also displayed a significant tendency to participate in the same protein complexes ([Figure 2---figure supplement 2J](#fig2s2){ref-type="fig"}). Finally, LC genes were preferentially recovered by a disease gene prediction algorithm when a subset of them were randomly withheld, and the remainder used to prioritize additional disease genes ([Figure 2F](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2G--I](#fig2s2){ref-type="fig"}). Thus, LC genes represent a biologically relevant and functionally coherent set of genes, which converge on a common protein interaction module within the human interactome.

Gene coexpression network analysis of human spinal cord {#s2-3}
-------------------------------------------------------

Multiple lines of evidence support the functional coherence of the set of genes implicated in SCI by small-scale experiments. However, these studies nonetheless have appreciable false positive and false negative rates, and are limited by sociological and experimental biases. We therefore sought to integrate knowledge from the SCI corpus within an unbiased, genome-wide framework. We hypothesized that unsupervised gene coexpression network analysis of human spinal cord would provide a powerful method to integrate these LC genes in a systems-level context, as this method has recently been powerfully applied to develop insights into the etiologies of a number of neurological ([@bib53]; [@bib18]; [@bib47]; [@bib91]) or psychiatric diseases ([@bib86]; [@bib11]; [@bib31]).

We constructed gene coexpression networks in human spinal cord using RNA-seq data from 71 post-mortem human spinal cords from the Genotype-Tissue Expression project (GTEx) ([@bib37]). We applied WGCNA ([@bib55]) to group the human spinal cord transcriptome into 15 distinct modules of coexpressed genes ([Supplementary file 2](#supp2){ref-type="supplementary-material"}). These modules represent networks of genes that share highly related patterns of expression in the human spinal cord. In order to establish the reproducibility of these spinal cord gene expression modules in an independent dataset, we constructed a second human spinal cord gene coexpression network from public microarray data, using established techniques to control for batch effects ([@bib58]; [@bib85]). Module conservation was quantified using the $Z_{\text{summary}}$ statistic ([@bib56]). Despite the small sample size of our microarray-based human spinal cord coexpression network (n = 33), seven of 15 modules showed strong evidence of reproducibility ($Z_{\text{summary}}$ \> 10), with an additional two modules showing moderate evidence of reproducibility ($Z_{\text{summary}}$ \> 5) ([Figure 3A](#fig3){ref-type="fig"}). Only two of 15 modules showed no evidence of reproducibility ($Z_{\text{summary}}$ \< 2).

![Gene coexpression modules in the human spinal cord and their differential expression in SCI.\
(**A**) Reproducibility of human spinal cord modules in a microarray dataset and conservation in mouse and rat. (**B**) Enrichment of M3 and M7 for LC SCI genes. (**C**) Robustness of M3 and M7 enrichment for LC SCI genes. (**D**) Eigengene network for human spinal cord modules. (**E**) Differential expression of spinal cord modules following SCI in five datasets, and consensus. (**F**) Evidence for differential expression of six consensus modules and one majority module (**M8**). (**G**) Time-dependent expression of spinal cord modules at acute, subacute, and chronic time points following SCI.](elife-39188-fig3){#fig3}

Next, we investigated the evolutionary conservation of human spinal cord coexpression modules in mouse and rat, two of the most commonly used model organisms for studies of SCI pathophysiology. We compiled hundreds of microarray samples from mouse (n = 414) and rat (n = 267) spinal cords from the Gene Expression Omnibus, and constructed gene coexpression networks for the mouse and rat spinal cords, again using established batch effect correction methods. Five modules showed strong evidence of evolutionary conservation ($Z_{\text{summary}}$ \> 10) in both species, while another four modules showed moderate evidence of conservation ($Z_{\text{summary}}$ \> 5) in at least one species, and only two modules showed no evidence of conservation in either species ($Z_{\text{summary}}$ \< 2) ([Figure 3A](#fig3){ref-type="fig"}). Notably, the same five modules that showed the strongest evidence of reproducibility (M2, M3, M7, M8, and M12) also showed the strongest evidence of conservation in rat and mouse. Thus, at least at the systems level, the architecture of the spinal cord transcriptome is substantially conserved between human and model organisms, supporting our approach of integrating data from small-scale studies of mammalian model organisms.

In order to integrate the LC gene set with the spinal cord coexpression network, we next tested for enrichment of LC genes within each module ([Figure 3B](#fig3){ref-type="fig"}). Two modules, M3 and M7, were significantly enriched for LC genes (Fisher's exact test, Bonferroni-corrected p = 9.5 $\times$ 10^−8^ and 2.7 $\times$ 10^−3^, respectively). These modules consist of 746 and 330 genes, respectively, and both are among the most reproducible and conserved in the spinal cord ([Figure 3A](#fig3){ref-type="fig"}). We confirmed the robustness of the observed enrichment by randomly removing seed genes from the LC set, and by randomly adding false positive genes to the LC set. Both M3 and M7 remained significantly enriched for LC genes despite the removal of a large number of seed genes, or the addition of a large number of random genes ([Figure 3C](#fig3){ref-type="fig"}): M3 remained significantly enriched for LC genes even after the removal of approximately 70% of genes from the seed set, compared to approximately 50% for M7. Moreover, M3 remained significantly enriched for seed genes even after the size of the literature-curated set was doubled by addition of random false positives. We also asked whether the observed enrichment was driven most strongly by any individual analytical technique or injury model, but found the majority of experimental methods, SCI models, and species contributed to the observed LC gene enrichment in M3 and M7 ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Thus, M3 and M7 are robustly enriched for genes associated to the SCI response by small-scale studies, despite their divergent experimental designs.

Finally, to assess the relationships between modules, we constructed a module meta-network based on the eigengene of each module, defined as the first principal component of module expression ([@bib54]) ([Figure 3D](#fig3){ref-type="fig"}). In the resulting network, M3 and M7 clustered together, as would be expected given the strong correlation between their eigengenes (Spearman's $\rho$ = 0.54, p = 1.6 $\times$ 10^−6^). These results suggest that the expression of these two modules in the spinal cord is highly correlated.

In summary, gene coexpression network analysis identified five highly conserved and reproducible modules, two of which are significantly and robustly enriched for LC genes, and whose expression is highly correlated.

Meta-analysis of coexpression network deregulation in SCI {#s2-4}
---------------------------------------------------------

We next characterized the role of M3 and M7, as well as other highly conserved coexpression modules, in the pathophysiological response to SCI. We performed a meta-analysis of five mouse and rat transcriptomic studies of SCI within the context of our spinal cord coexpression network, in order to identify consensus changes in the spinal cord transcriptome at the module level in response to SCI ([Figure 3E](#fig3){ref-type="fig"}). This analysis identified M3, M6, M7, and M11 as consensus upregulated, and M1 and M2 as consensus downregulated, following SCI. One other module, M8, was upregulated following SCI in four of five datasets, while the remaining eight modules did not show robust evidence of differential expression. Among all seven modules, M2, M3, and M7 consistently showed the strongest evidence of differential expression ([Figure 3F](#fig3){ref-type="fig"}, p $\leq$ 6.5 $\times$ 10^−36^, 1.2 $\times$ 10^−48^, and 1.6 $\times$ 10^−14^, respectively). Notably, among these modules, M2, M3, M7 were strongly conserved and reproducible in mouse, rat, and human networks ($Z_{\text{summary}}$ \> 10), whereas M1, M6, and M11 displayed only moderate evidence of conservation (2 \< $Z_{\text{summary}}$ \< 10), suggesting these modules may capture human-specific aspects of spinal cord transcriptome organization that are relevant in the response to SCI.

Because the pathophysiological processes underlying primary and secondary injury in SCI are incompletely understood, we additionally investigated the expression of spinal cord modules at acute, subacute, and chronic time points. Consensus module expression was remarkably consistent at all time points studied ([Figure 3G](#fig3){ref-type="fig"}). However, analysis of the temporal regulation of spinal cord modules revealed consensus downregulation of M9 at the most acute time point after SCI, but consensus upregulation at a chronic time point. These results suggest M9 may be specifically involved in the transition between acute and chronic physiological responses following SCI. Thus, by integrating gene coexpression network analysis with a meta-analysis of the SCI transcriptome, we reveal a consensus network signature associated with the response to SCI, and a network module specifically implicated in the transition from acute to chronic injury processes.

Functional characterization of consensus signature modules {#s2-5}
----------------------------------------------------------

We sought to characterize the biological significance of the modules implicated in the physiological response to SCI by integrating functional annotations from the Gene Ontology ([@bib4]) and molecular signatures from MSigDB ([@bib61]) ([Supplementary file 3](#supp3){ref-type="supplementary-material"}). To visualize statistically overrepresented gene sets, we constructed enrichment maps for each consensus signature module ([@bib67]) ([Figure 4A--B](#fig4){ref-type="fig"} and [Figure 4---figure supplements 1](#fig4s1){ref-type="fig"}--[4](#fig4s4){ref-type="fig"}). To appreciate the cell type-specificity of each module, we additionally conducted a meta-analysis of transcriptomic and proteomic profiles from the major cell types of the CNS, incorporating both bulk and single-cell RNA-seq datasets ([@bib93]; [@bib77]; [@bib8]; [@bib90]) ([Figure 4C](#fig4){ref-type="fig"} and [Figure 4---figure supplement 5](#fig4s5){ref-type="fig"}). M1 was an oligodendrocyte module, associated with axon ensheathment and myelination, whereas M2 was a neuronal module implicated in synaptic transmission. M3 was enriched for markers of microglia and vascular endothelial cells, and biological processes such as inflammatory response and response to wounding, while M7 was a microglial module enriched for annotations related to the immune response. M9 was enriched for astrocyte markers and terms such as oxidation-reduction process, as well as the term central nervous system development, which may be related to its upregulation at chronic time points following SCI. M6 and M11 were not significantly associated with any specific cell type, and were enriched for terms including cellular protein modification process and mitochondrial translation, respectively.

![Biological characterization of spinal cord modules.\
(A--B) Enrichment maps ([@bib67]) for modules M3 and M7. (**C**) Meta-analysis of cell type-specific marker gene enrichment in human spinal cord modules at the transcriptomic and proteomic levels.](elife-39188-fig4){#fig4}

Network analysis of SCI severity and recovery {#s2-6}
---------------------------------------------

The finding that M3 is a highly conserved and reproducible gene coexpression module, with the most significant enrichment for LC genes and strong evidence of upregulation following SCI, suggested that this module plays a key pathophysiological role in SCI. We focused on the role of M3 in SCI by investigating the relationship between M3 expression and two key clinical parameters in SCI: injury severity and recovery of sensory and motor function.

We first re-analysed gene expression data from a mouse model of severity-dependent injury to identify relationships between consensus module expression and injury severity ([@bib20]; [@bib17]). Strikingly, M3 was the sole module enriched for genes positively correlated to injury severity, whereas M1, M2, and M9 were enriched for genes anti-correlated to injury severity ([Figure 5A](#fig5){ref-type="fig"}). We investigated this effect further by considering the correlations between module eigengenes, which provide a summary of the expression profile of each module, and injury severity. This analysis revealed that the M3 eigengene was the most strongly correlated with injury severity (Spearman's $\rho$ = 0.79, p = 2.5 $\times$ 10^−7^), with a clear separation in M3 expression between the mild, severe, and sham injury groups at 7 days post-injury ([Figure 5E](#fig5){ref-type="fig"}).

![Relationship of spinal cord modules to injury severity and functional recovery.\
(**A**) Enrichment of spinal cord modules for genes correlated or anticorrelated to injury severity in a mouse model. (**B**) Consensus network signature of SCI pathophysiology, validation in independent transcriptomic and proteomic datasets, and reversal in functional recovery and reduced axonal dieback. (**C**) Gene expression correlation to M3 eigengene predicts association to SCI severity. (**D**) Reproducibility and evolutionary conservation of spinal cord modules and their preservation at the proteomic level. (E--F) Relationship between M3 eigengene and injury severity at 7 days post-injury in a mouse model (**E**), and in our own RNA-seq (**F**) and proteomic (**G**) datasets. (**H**) Downregulation of the M3 eigengene following treatment with NT-3, a neurotrophic agent that promotes functional recovery in acute SCI. (**I**) Six genes classify moderate and severe injuries in transcriptomic data with 90% or greater accuracy. (J--K) Gene expression and protein abundance of annexin A1 in sham, moderate, and severe SCI.](elife-39188-fig5){#fig5}

In order to validate the severity-dependent upregulation of M3 following SCI, we conducted a prospective experimental SCI study, using the field standard contusion injury model at the T10 segment, and performed RNA sequencing of the spinal cord parenchyma in rats subjected to moderate, severe, or sham injuries (*n* = 5 per group). Our RNA-seq data reproduced the consensus network signature derived from our meta-analysis of microarray datasets, emphasizing the robustness of this systems-level characterization of SCI pathophysiology ([Figure 5F](#fig5){ref-type="fig"}). In addition, we confirmed the significant association between injury severity and the M3 eigengene ([Figure 5E](#fig5){ref-type="fig"}; Spearman's $\rho$ = 0.94, p = 4.2 $\times$ 10^−7^). Thus, insights into the network-level organization of the transcriptome in SCI derived from a meta-analysis of publicly available data replicate in an independently collected dataset.

Together, these results emphasized the severity-dependent upregulation of M3 following SCI, and suggested that the expression of a gene or combination of genes that accurately summarize the transcriptional status of M3 has the potential to serve as an objective biomarker of SCI severity. To evaluate the potential of such an indicator as a biomarker of injury severity, we focused on the hub genes of M3. These genes are the most central and interconnected within the module, based on their correlation to the module eigengene, and are highly enriched for functionally relevant genes such as drivers of disease pathophysiology ([@bib86]) or therapeutic targets ([@bib40]). Consistent with these findings, the hubness of M3 genes (that is, their correlation to the M3 eigengene in human spinal cord) was significantly associated with their predictive power as a biomarker of injury severity ([Figure 5D](#fig5){ref-type="fig"}; Spearman's $\rho$ = 0.23, p = 3.9 $\times$ 10^−7^). Among M3 hubs, six genes stratified rats by SCI severity with an accuracy greater than 90%, including *Anxa1*, *Colgalt1*, *Ifngr2*, *Shc1*, *Sod2*, and *Tbc1d2b* ([Figure 5G](#fig5){ref-type="fig"}). Remarkably, expression levels of *Anxa1* (annexin A1) stratified moderately and severely injured rats with perfect accuracy ([Figure 5I](#fig5){ref-type="fig"}). Annexin A1 has previously been associated with SCI by three small-scale studies, each employing divergent model organisms, spinal cord levels, and injury models, emphasizing the robustness of the association between SCI and annexin upregulation ([@bib21]; [@bib68]; [@bib32]).

While our integrative analyses of public and newly acquired transcriptomic data established a strong relationship between M3 expression and SCI severity, post-transcriptional regulation can result in marked differences between gene and protein expression levels, particularly in complex tissues such as those of the CNS ([@bib77]; [@bib30]). To further explore the potential of M3 hubs as biomarkers of SCI severity, we therefore performed quantitative proteomic profiling of the same rat spinal cords. We first sought to establish that the overall structure of the spinal cord coexpression network was conserved between the transcriptomic and proteomic levels. Despite having limited power to detect module preservation due to the small size of our proteomic sample (*n* = 15), both M3 and M7 displayed highly significant evidence of reproducibility between the RNA and protein levels ([Figure 5C](#fig5){ref-type="fig"}; $Z_{\text{summary}}$ = 6.8 and 7.3, respectively). Furthermore, we identified substantial overall agreement between proteomic data and the consensus network signature derived from transcriptomic meta-analysis, further validating the robustness of our systems-level portrait of SCI pathophysiology ([Figure 5F](#fig5){ref-type="fig"}). Finally, we confirmed the severity-dependent upregulation of both the M3 eigengene and annexin A1 in particular ([Figure 5H and J](#fig5){ref-type="fig"}), finding that ANXA1 protein levels stratified both moderate and severe injuries with an accuracy of 93%. Thus, systems-level insights into SCI pathophysiology derived from integrative transcriptomic analyses extend to the proteomic level and nominate quantitative biomarkers of SCI severity.

Given the strong relationship between injury severity and M3 expression, we hypothesized that targeting the transcriptional profile of this module could represent a viable strategy for development of novel therapies for SCI. To explore this hypothesis, we analyzed gene expression data from a recent trial of a neurotrophic factor, neurotrophin-3 (NT-3), which promoted sensory and motor recovery after SCI ([@bib25]; [@bib88]). Remarkably, all six consensus modules derived from our meta-analysis, including M3, were differentially expressed at the lesion site in the opposite direction ([Figure 5F](#fig5){ref-type="fig"}) in rats treated with NT-3. Intriguingly, the sole other differentially expressed module was M9, which we previously observed to exhibit a strongly time-dependent expression profile, and which was enriched for genes associated with neurogenesis. In rats treated with NT-3, known for its role in neuronal differentiation, axonal growth, and chemotropic guidance ([@bib2]; [@bib3]), M9 was strongly upregulated at the lesion site relative to the experimental control (p = 9.3 $\times$ 10^−12^). Moreover, the M3 eigengene was significantly downregulated in NT-3-treated rats relative to controls ([Figure 5K](#fig5){ref-type="fig"}; one-tailed Wilcoxon rank-sum test, p = 2.1 $\times$ 10^−3^). We additionally analysed gene expression data from transgenic STAT3 knockout mice ([@bib3]), a loss-of-function manipulation that increased axonal dieback following experimental SCI, and found all six consensus modules were again differentially expressed in the opposite direction in wild-type mice, relative to knockout mice ([Figure 5B](#fig5){ref-type="fig"}). These results indicate that reversal of the transcriptome changes observed in response to SCI is associated with functional recovery and decreased axonal dieback in rodent models, and highlight M3 expression as a predictor of functional recovery.

Discussion {#s3}
==========

The fragmentary understanding of the coordinated pathophysiological processes activated in the human spinal cord by SCI represents a central obstacle to the development of therapies capable of influencing neurological outcomes. In this study, we developed an integrated, systems-level approach to understand the molecular mechanisms underlying SCI pathophysiology. We leveraged large-scale RNA-seq data from healthy subjects to reveal gene regulatory relationships in the human spinal cord. By integrating multiple gene expression datasets from experimental models of SCI, we identified gene subnetworks implicated by consensus in the pathophysiological response to SCI, and reproduced these signatures at both the transcriptomic and proteomic levels in an animal trial. The observation that seven different gene modules were robustly associated with the response to SCI, either by consensus differential regulation (M1, M2, M3, M7, M11) or by a strongly time-dependent course of expression (M9), is consistent with the notion that the pathophysiology of SCI is highly complex ([@bib74]). Our results provide a framework to understand the diverse, coordinated processes in the spinal cord following SCI.

In order to prioritize gene subnetworks, we conducted a systematic analysis of the SCI literature, and integrated genes implicated in the SCI response by small-scale experiments into our network analysis. This approach is conceptually similar to the integration of GWAS or *de novo* mutation data into gene regulatory networks, as has previously been described for a number of diseases (e.g., [@bib47]; [@bib18]; [@bib9]; [@bib59]; [@bib42]). In the context of genetic analyses, the core assumption is that false positive and false negative associations between alleles and the phenotype of interest can be mitigated by identifying convergent molecular processes that mediate disease biology. In the context of literature curation, as employed here, we posit that the relatively high false-positive rates of small-scale experiments, as well as their appreciable false-negative rates, can be mitigated by unbiased integration of data from small-scale experiments into a genome-wide framework. Importantly, this experimental design provides an approach to extend gene coexpression network analysis to acquired and traumatic conditions, using samples from healthy tissues. However, a limitation of this approach is the implicit assumption that the molecular organization of the transcriptome in the relevant tissue of healthy human subjects is informative about the biological processes dysregulated by an acquired or traumatic condition. Although the analyses presented here indicate that this assumption appears to be valid in the case of SCI, future work will be needed to establish whether this principle holds in general.

A major challenge to the translation of preclinical therapies for acute SCI is the use of standardized neurological assessments to enrol and stratify patients in large clinical trials ([@bib28]). In this context, objective biomarkers capable of accurately stratifying injury severity have the potential to facilitate translation by accelerating the pace of patient enrolment ([@bib52]; [@bib82]). We found that M3 was the sole module enriched for genes whose expression correlated with injury severity in a mouse model, and that its eigengene was likewise most strongly associated with severity. We subsequently reproduced this correlation in our own transcriptomic and proteomic datasets. The severity-dependent upregulation of M3 following SCI, and its preservation at the proteomic level, suggests that its expression has the potential to stratify injury severity in a clinical context. Furthermore, this expression pattern was reversed with administration of NT-3, a treatment that promotes motor and sensory recovery ([@bib88]). These findings have several implications for the discovery and translation of new SCI therapies. The identification of drugs that reverse transcriptional changes associated with SCI has the potential to provide a new strategy for preclinical lead discovery. Moreover, analysing the effect of a desired treatment on M3 expression, or our consensus network signature more generally, may represent an effective technique to validate the efficacy of preclinical therapies.

Among M3 hub genes, which reflect the expression of the entire module, we found that both the RNA and protein levels of *Anxa1* (annexin A1) demonstrated a strong ability to discriminate between injuries of different severities. Annexin A1 is a member of the annexin superfamily of calcium dependent phospholipid-binding proteins, and plays a role in mediating anti-inflammatory effects through inhibition of phospholipase A2 activity ([@bib27]; [@bib63]), decreasing leukocyte activation ([@bib72]; [@bib15]) and reducing expression of pro-inflammatory cytokines ([@bib83]; [@bib65]). *Anxa1* is primarily expressed in microglia, where it regulates the selective removal of apoptotic neurons ([@bib65]). Correspondingly, *Anxa1* knockout mice are characterized by exaggerated inflammatory responses, as well as a blunted response to the anti-inflammatory effects of glucocorticoids ([@bib38]). *Anxa1* is upregulated in multiple diseases characterized by aberrant neuroinflammation ([@bib26]; [@bib27]; [@bib65]). Importantly, multiple studies have previously reported upregulation of *Anxa1* in SCI ([@bib21]; [@bib68]; [@bib32]), with peak expression at 7 days post injury ([@bib62]), and upregulation of *Anxa1* is associated with functional recovery after SCI ([@bib63]). Notably, *Anxa1* was previously identified as a biomarker of SCI severity in a study that included both rat and human samples ([@bib68]). Our independent finding here that *Anxa1* is a strong candidate for a severity-dependent biomarker of SCI suggests that our systems-level approach can drive rational selection of novel potential biomarkers. However, although we observed substantial conservation of M3 between human and rat at the systems level, this finding does not preclude the possibility that individual genes diverge in their expression following acute SCI between human and rodents. Further studies in humans are therefore needed to conclusively establish the validity of *Anxa1* as a biomarker of SCI severity.

In summary, our systems biology approach identifies evolutionarily conserved and reproducible gene subnetworks with robust evidence for differential regulation following SCI, and provides a genome-wide view of the pathophysiological processes triggered by SCI. Our findings provide new, data-driven strategies to identify and translate novel therapies for SCI.

Materials and methods {#s4}
=====================

Systematic analysis of SCI literature {#s4-1}
-------------------------------------

We searched PubMed for articles investigating the molecular pathophysiology of SCI published prior to February 2016, using combinations of 'spinal cord injury' and one of 'proteomics,' 'proteome,' 'proteomic,' 'biomarkers,' 'biomarker,\' 'RNA-seq,' and 'microarray' as search terms. 556 papers were identified that met these criteria. These were subsequently filtered to exclude papers that did not include a valid control group, included exclusively in vitro data, did not include primary data, or examined a tissue other than spinal cord. As previous studies have suggested that small-scale and high-throughput experiments may be largely complementary, or lead to divergent biological conclusions, we considered only small-scale experiments in the literature curation process, defined here as experiments reporting differential regulation of fewer than 100 genes or proteins. Ultimately, data from 67 manuscripts was collected. The original accessions used to identify genes or proteins associated with SCI in each publication were retained. If only the gene name and no unambiguous identifier was noted, the UniProt accession of the gene in the relevant species was manually retrieved. We applied a strict, majority voting-based method to map rat, mouse, and rabbit genes to their human orthologs with maximum accuracy ([@bib60]). Specifically, we mapped orthologs from rat, mouse, and rabbit genes to human using seven different ortholog databases \[EggNOG ([@bib45]), Ensembl ([@bib50]), NCBI Gene ([@bib7]), HomoloGene ([@bib1]), InParanoid ([@bib79]), and OrthoDB ([@bib89])\], and considered human genes as 'consensus orthologs' only if they were detected in at least half of those databases containing an entry for the target model organism protein. All genes were mapped to Ensembl identifiers in Bioconductor ([@bib44]).

Validation of literature-curated SCI genes {#s4-2}
------------------------------------------

We established the functional coherence and biological relevance of our LC SCI gene set using four lines of evidence: protein-protein interactions (PPIs), interactome largest connected components (LCCs), shared Gene Ontology (GO) terms, and recovery with DIAMOnD ([@bib35]), a disease gene prediction algorithm. To investigate the tendency of our LC gene set to participate in PPIs, we initially analysed a recently described high-quality human interactome ([@bib66]). We subsequently reproduced our results in two additional human interactome databases restricted to binary and co-complex interactions, obtained from HINT (version 4) ([@bib16]), and a fourth human interactome, obtained from InBioMap ([@bib60]), in order to establish that the enrichment for protein-protein interactions was not a function of the experimental technique used to detect the interaction. Self-interactions were removed and original accessions were mapped to Ensembl gene identifiers. To evaluate the impact of the experimental method used to detect PPIs, we analysed high-quality binary and co-complex interactomes from HINT separately. Network operations, including creation of induced subgraphs and calculation of largest connected components, were performed in the R package igraph ([@bib14]). Randomized networks were generated using a degree-preserving algorithm ([@bib64]) to control for network topology, with 1000 randomized networks generated to calculate empirical P values. We additionally evaluated the tendency for LC proteins to participate in the same protein complexes by retrieving random sets of proteins of equivalent size from hu.MAP ([@bib24]) and calculating the number of co-complex interactions, a process that was repeated 10^3^ times.

GO terms were retrieved from the UniProt-GOA database ([@bib22]). We compared the number of shared GO terms within each ontological category at three breadth cutoffs between all pairs of LC genes to the number of shared GO terms between random sets of genes.

To evaluate the ability of a recently described algorithm for disease gene prioritization, DIAMOnD, we randomly withheld 20% of LC genes and evaluated the fraction recovered within the first 1000 iterations of DIAMOnD. This was compared to the ability of DIAMOnD to recover an equivalent number of randomly selected genes, using randomly selected seed genes from the human genome. This process was bootstrapped 1000 times and results were reproduced using the InWeb_InBioMap interactome (version 2016_09_12) ([@bib60])

Gene coexpression network analysis of human spinal cord {#s4-3}
-------------------------------------------------------

Raw gene read count and RPKM data was downloaded from the GTEx portal, version V6p ([@bib37]). Only genes with expression estimates \> 0.1 RPKM in $\geq$ 10 individuals were considered. The distribution of RPKMs in each sample was quantile transformed using the average empirical distribution observed across all samples, and inverse quantile normalization to the standard normal distribution was performed for each gene. Gene coexpression analysis was performed using the WGCNA package [@bib55]. Briefly, a signed pairwise gene correlation matrix was constructed using biweight midcorrelation ([@bib57]) and considering a maximum of 5% of samples as outliers on either side of the median. The correlation matrix was raised to the power $\beta$ = 5, the minimum value satisfying the scale-free topology criterion R^2^ $>$ 0.8, to create an adjacency matrix. The adjacency matrix was used to calculate the topological overlap matrix (TOM), which was subsequently clustered based on the dissimilarity of gene connectivity. Coexpressed gene modules were defined from the resulting tree using the dynamic tree cut method ([@bib55]), with a minimum module size of 20 and a cut height of 0.2.

Module preservation in human, rat, and mouse microarray data {#s4-4}
------------------------------------------------------------

We queried Array Express ([@bib51]) with the search term 'spinal cord' to identify samples from Affymetrix GeneChip Rat Genome 230 2.0, Human Genome U133 Plus 2.0, and Mouse Genome 430 2.0 microarrays ([Supplementary file 3](#supp3){ref-type="supplementary-material"}). Experiments with fewer than five samples were excluded. Additionally, experiments or samples analysing individual cell populations (e.g., neurons) within the spinal cord rather than homogenized tissue, fetal spinal cord, or spinal cord neoplasms were excluded. Raw expression profiles were normalized with the MAS5 algorithm ([@bib43]) within the R package affy ([@bib33]). Only probe sets that were called as present in at least 80% of samples were retained. ComBat was used to adjust for batch effects, where each experiment corresponded to a single batch ([@bib58]). Affymetrix probe set identifiers were mapped to Ensembl gene accessions using Bioconductor. Genes with multiple probes were represented by the median expression value. Mouse and rat accessions were further mapped to consensus human orthologs using the majority-voting procedure described above. Module preservation was assessed using the $Z_{\text{summary}}$ statistic, calculated using the modulePreservation function in the WGCNA R package with 100 permutations.

Meta-analysis of coexpression network deregulation following SCI {#s4-5}
----------------------------------------------------------------

Data from five studies investigating the transcriptomic response to SCI (GSE464, GSE5296, GSE45006, GSE45376, and GSE69334) was obtained from Array Express. Normalization and mapping to human orthologs was performed as described above. For GSE464, MAS5 normalization was performed within the R package xps, as the Rat Genome U34 chip was not supported by the affy package. For GSE45376, quantile normalization of raw expression estimates was performed as described for GTEx data. Differential expression analyses of each processed dataset were performed with treatment-contrasts parameterization in the limma package ([@bib75]), using the geneSetTest function to perform a mean-rank gene-set enrichment test for both up- and downregulation of each module, before applying Bonferroni correction. We additionally analysed differential expression of each module at 1 day, 3 days, 7 days, and 28 days following SCI in order to evaluate module expression at acute, subacute, and chronic time points.

Functional characterization of spinal cord modules {#s4-6}
--------------------------------------------------

To construct enrichment maps for consensus modules implicated in the response to SCI by meta-analysis, we identified overrepresented gene sets from GO ([@bib22]) and the CGP (chemical and genetic perturbagens) and TFT (transcription factor targets) subsets of MSigDB ([@bib61]). Genes were mapped to Ensembl accessions prior to enrichment analysis with the HTSanalyzeR package ([@bib87]), using 1000 permutations and a minimum gene set size of 5. Significantly enriched gene sets were visualized as an enrichment map ([@bib67]), in which nodes represent gene sets and edges connect related gene sets. Clusters of gene sets within the resulting enrichment maps were manually identified and annotated. Cell type specificity was assessed using microarray ([@bib8]), RNA-seq ([@bib93]), and proteomic ([@bib77]) data from cell populations within the mouse CNS, using the R package pSI to test for enrichment of cell type-specific genes ([@bib23]). We analysed a wide range of cell types, including neurons, astrocytes, and microglia ([@bib8]; [@bib93]; [@bib77]), as well as oligodendrocytes at various points in maturation (i.e., 'oligodendrocyte precursor cell,' 'myelinating oligodendrocyte,' 'oligodendrocyte;' \[[@bib8]; [@bib93]\]). We included additional comparisons in microglia from both new-born and adult mice (i.e., 'adult microglia,' 'young microglia;' \[[@bib77]\]), developing in vitro neurons and oligodendrocytesthrough the first two weeks of maturation (DIV: day in vitro; \[[@bib77]\]), as well as isolated and cultured astrocytes ([@bib8]).

Severity-dependent expression of spinal cord modules {#s4-7}
----------------------------------------------------

Raw microarray data was obtained from Array Express (GSE464) ([@bib51]; [@bib17]) and processed as described above. Injuries annotated as 'moderate' and 'severe' were grouped together on the basis of identical histological and functional outcomes in the experimental model ([@bib17]). To identify modules enriched for genes whose expression was correlated with injury severity, we calculated a previously described gene-level score ([@bib18]) by multiplying the Spearman correlation coefficient between gene expression and height of weight drop by the negative logarithm of the P value, then performed mean-rank gene-set enrichment tests and applied Bonferroni correction. Only samples from the lesion site were considered. Initial analysis of differentially expressed genes revealed that all but a single probe set on the U34A chip were consistently downregulated following injury, likely due to the biased composition of this chip. Therefore, samples collected using this chip were omitted when calculating correlation between injury severity and module eigengenes to reduce bias. Module eigengenes were calculated using the moduleEigengenes function from the WGCNA package.

Spinal cord surgery and animal care {#s4-8}
-----------------------------------

Ethical approval was obtained by the University of British Columbia Behavioural Research Ethics Board (A14-0152) and all procedures strictly adhere to the guidelines issues by the Canadian Council for Animal Care. Animals (n = 15, n = 5 per group) were started on prophylactic enrofloxin (Baytril; 10 mg kg^−1^, s.c., Associated Veterinary Purchasing (AVP), Langley, Canada) three days prior to surgery. On the day of spinal cord contusion animals were anesthetized using isoflurane (initialinduction 5% and maintained on a Bain's system at 2%). After achieving surgical depth of anaesthesia, pre-operative buprenorphine (Temgesic; 0.02 mg kg^−1^, s.c., McGill University), enrofloxin (Baytril; 10 mg kg^−1^, s.c., Associated Veterinary Purchasing (AVP), Langley, Canada), and Ringers solution were administered subcutaneously. The skin was prepared by shaving the surgical site, followed by three successive chlorohexidine and 70% ethanol washes. A dorsal midline incision was made from T5 to L2. The T9 spinous process was identified and a laminectomy was performed to expose the T10 spinal segment. Following this the animal was transferred to the IH impactor stage, where the T8 and T10 spinous processes were securely clamped using modified Allis forceps. The animal was stabilized on the platform and the impactor tip (2.0 mm) was properly aligned using a 3-dimensional coordinate system moving platform. The position of the impactor was confirmed as midline by two separate experimenters. The IH system was set to deliver an impact of 100 or 200 kdyn of pre-defined force, based on random assignment. Following hemostasis, the deep and superficial Para spinal muscles were sutured using 5--0 Monocryl sutures (Ethicon, USA), followed by 5--0 Prolene (Ethicon, USA) sutures in the skin. Animals were then given 5 mL of Ringers solution subcutaneously and allowed to recover in a temperature controlled environment (Animal Intensive Care Unit, Los Angeles, CA, USA). Post-operatively, animals were given buprenorphine (10 mg kg^−1^, s.c.) and enrofloxin (0.02 mg kg^−1^, s.c.) once daily for three days, after which buprenorphine was given on an as needed basis. Bladders were manually expressed for the duration of the experiment (7 days post-injury).

Tissue processing {#s4-9}
-----------------

Animals were overdosed with a lethal dose of 10% chlorohydrate (i.p.), after which a thoracotomy was performed. Animals were transcardially cleared with 300 mL of PBS. Next, the spinal cord lesion site was dissected 2 mm caudal and rostral to the visual epicentre. This sample was homogenized and split into two parts for transcriptomic and proteomic processing.

RNA isolation and sequencing {#s4-10}
----------------------------

10 mg of spinal cord parenchyma surrounding the injury site was stored in RLT buffer containing beta-mercaptoethanol until RNA isolation. Total RNA was purified using the Qiagen RNeasy Mini Kit according to the manufacturer's instructions, eluting in 30 $\mu$L of water. 500 ng RNA was used for library preparation with Illumina's TruSeq Stranded mRNA kit (Illumina, San Diego, CA). Libraries were pooled and sequenced on the Illumina NextSeq in high output mode, generating paired-end 75-base pair reads. Library preparation and sequencing were performed by the Sequencing and Bioinformatics Consortium at the University of British Columbia.

Transcriptome analysis {#s4-11}
----------------------

Quality control checks using FastQC and principal components analysis revealed a single sample as an outlier, which was discarded prior to further analysis. Sequences were pseudoaligned to the Ensembl 89 version of the Rattus norvegicus transcriptome, including coding and non-coding transcripts, with Salmon (version 0.8.2) ([@bib71]), using 100 bootstraps to compute abundance estimates. Rat genes were mapped to human orthologs using the majority-voting procedure described above. Salmon outputwas converted into a format compatible with sleuth ([@bib73]) for differential expression analysis using wasabi (<https://github.com/COMBINE-lab/wasabi>). Differential expression was assessed using sleuth (version 0.29.0), representing severity as a continuous covariate (0, 100, or 200 kdyn of force). Genes were ranked by the fold change estimates computed by sleuth to perform mean-rank gene-set enrichment tests for module up- and downregulation. Hub genes were identified by ranking genes by their correlation to the module eigengene in the human spinal cord samples ([@bib41]), and identifying the 10% most connected genes in the module. To evaluate the ability of hub gene expression to stratify SCI severity, we constructed linear discriminant analysis models using the R package MASS ([@bib52]). The accuracy of each model in classifying moderately and severely injured rats was assessed using leave-one-out cross-validation.

Mass spectrometric analysis {#s4-12}
---------------------------

Parenchyma tissue samples were lysed by 2.8 mm ceramic bead (Qiagen) prior to homogenization with a single 20 s 5000 rpm on Precellys 24 (Bertin Technologies) in 4% (w/v) SDS in 100 mM Tris pH 8.8 and 20 mM DTT. The lysate was heated at 99${}^{c}$C for 10 min, and cell debris was spun out and protein concentration estimated by BCA assay (Thermo). An equivalent protein amount for each sample was loaded onto 10% SDS PAGE gel and visualized by colloidal Coomassie ([@bib10]). Each lane was fractionated into five pieces and trypsin digested out of the gel ([@bib78]). Peptide samples were purified by solid phase extraction on C-18 Stop And Go Extraction (STAGE) Tips ([@bib46]), and analysed by a quadrupole--time of flight mass spectrometer (Impact II; Bruker Daltonics) coupled to an Easy nano LC 1000 HPLC (ThermoFisher Scientific) using an analytical column that was 40--50 cm long, with a 75 $\mu$m inner diameter fused silica with an integrated spray tip pulled with P-2000 laser puller (Sutter Instruments), packed with 1.9 $\mu$m diameter Reprosil-Pur C-18-AQ beads (Maisch, <http://www.dr-maisch.com>), and operated at 50${}^{\circ}$C with in-house built column heater. Buffer A consisted of 0.1% aqueous formic acid, and buffer B consisted of 0.1% formic acid in acetonitrile. A standard 60 min peptide separation was done per injection, and the column was washed with 100% buffer B before re-equilibration with buffer A. The Impact II was set to acquire in a data-dependent auto-MS/MS mode with inactive focus fragmenting the 20 most abundant ions (one at the time at a 18 Hz rate) after each full-range scan from m/z 200 to m/z 2000 at 5 Hz rate. The isolation window for MS/MS was 2--3 depending on the parent ion mass to charge ratio, and the collision energy ranged from 23 to 65 eV depending on ion mass and charge. Parent ions were then excluded from MS/MS for the next 0.4 min and reconsidered if their intensity increased more than five times. Singly charged ions were excluded from fragmentation.

Analysis of mass spectrometry data was performed using MaxQuant ([@bib12]) version 1.5.3.30. The search was performed against a database comprised of the protein sequences from Uniprot Rattus norvegicus entries plus common contaminants with variable modifications of methionine oxidation, and N-acetylation of the proteins, and enabling LFQ and match between run options. Only those peptides exceeding the individually calculated 99% confidence limit (as opposed to the average limit for the whole experiment) were considered as accurately identified.

Proteomic analysis {#s4-13}
------------------

Module preservation at the proteomic level was quantified using the modulePreservation function, using Spearman correlation to calculate coexpression similarity. A mean-rank gene set enrichment test was used to test for module up- and downregulation, prior to Bonferroni correction. Linear discriminant analysis of annexin A1 was performed as described above.

Code availability {#s4-14}
-----------------

The source code to reproduce all the analyses and generate the figures reported in this paper is available under the MIT license from <https://github.com/skinnider/spinal-cord-injury-elife-2018> ([@bib81]); copy archived at <https://github.com/elifesciences-publications/spinal-cord-injury-elife-2018>.

Data availability {#s4-15}
-----------------

RNA sequencing data have been deposited to the GEO repository with the accession GSE115067. Proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD010192.
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Decision letter

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Integrated systems analysis reveals conserved gene networks underlying response to spinal cord injury\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Ole Kiehn as the Reviewing Editor and Patricia Wittkopp as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Tune Pers (Reviewer \#1); Andrea Tedeschi (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The study by Squair et al. use an integrative approach to identify a set of genes predictive for spinal cord injury (SCI) severity and functional recovery. They use a combination of systematic literature reviews and WGCNA on public gene databases to develop a gene set enrichment analysis and consensus SCI network conserved in many species. They then perform functional enrichment analyses using cell-based ontologies and protein network analyses to validate the selected gene sets. They identify a microglia/vascular cell network (\'M3\') and an innate immune response microglia network (\'M7\') correlated with injury severity and functional recovery, respectively. Some of the most connected genes in the M3 gene was also found to be downregulated in a dataset where neurotrophin-3 (NT3)-coupled chitosan biomaterial was grafted into a gap of completely transected rat thoracic spinal cord. The systems approach applied to spinal cord injury is novel and the pipeline is well presented and spans over a large number of relevant experimental and computational techniques, which complement each other very well. The work is important and will most probably have an impact in SCI.

Essential revisions:

The reviewers were generally very supportive of the work as presented but had a number of comments and specific request for improving the work and its impact.

A\) Additional analysis:

1\) The literature curated genes share more protein-protein interactions (PPI). However, biases in the PPI database towards small-scale studies could confound the analysis. The authors should redo their analysis based on PPI data restricted to interactions from large-scale screens only (e.g. from the InWeb or, if possible, HINT database). The same bias may exist for the validation analysis focusing on the size of the largest connected component and the DIAMOnD analysis.

2\) The authors should attempt to provide additional cell type specificity to the modules including M3 and M7 by using single cell RNA sequencing data from the spinal cord the following studies: a) www.biorxiv.org/content/early/2018/04/06/294918, b) Neuronal atlas of the dorsal horn defines its architecture and links sensory input to transcriptional cell types. Nature Neuroscience 2018; c) Massively Parallel Single Nucleus Transcriptional Profiling Defines Spinal Cord Neurons and Their Activity during Behavior, Cell 2018.

B\) Request for deposit of material:

The authors should put together a Github repository with all of the code used to perform the extensive analyses represented here. Given that the large majority of the work product here is in silico analysis of existing public resources, it seems only right for the authors to give back to the community so that each figure can be re-constructed from source code they make publicly-available. This is critical for reproducibility.

C\) Comments that may be addressed in the text:

1\) In genetics, less than 4% of the results from small-scale approaches (candidate gene analyses) have not been robustly replicated (Hirschhorn, Genetics in Medicine 2002). The authors should comment on: What are the potential reasons that a literature-seed gene approach seems to work well for SCI? What were the characters of the literature small-scale study approaches and experimental techniques that yielded the most predictive genes for the M3 and M7 networks -- any clear trends? Finally, were the M3 and M7 networks the top results in the RNA sequencing experiment, or were there WGCNA networks (or differentially expressed genes) stronger correlated with injury severity and functional recovery than the M3 and M7 networks, which would suggest additional relevant SCI pathways currently less well captured in literature?

2\) The literature curated genes coalesce on common biological functions that depends on them being accurately annotated. Could the author comment if there is bias towards literature genes even if genes have to be annotated to at least three Gene Ontology terms?

3\) The authors should mention that the assumption underlying their work is that gene expression data in control individuals is indicative of processes dysregulated in SCI. Even so this assumption seems to hold true in their case it remains to be shown whether it holds true in general.

4\) As most inflammatory mediators are expressed at low levels in the uninjured spinal cord, and the subsequent increase in expression is a response to injury, they are likely to correlate with SCI severity. It may therefore be suspected to find a M3 module enriched for markers of microglia positively that correlate positively with injury severity. The authors could have consider to expand the significance of their work by including additional analysis from another publicly available dataset where a different strategy was shown to promote functional recovery after SCI. In absence of this analysis the authors should discuss the general predictivity of their analysis with respect to the different modules.

10.7554/eLife.39188.036

Author response

> Essential revisions:
>
> The reviewers were generally very supportive of the work as presented but had a number of comments and specific request for improving the work and its impact.
>
> A\) Additional analysis:
>
> 1\) The literature curated genes share more protein-protein interactions (PPI). However, biases in the PPI database towards small-scale studies could confound the analysis. The authors should redo their analysis based on PPI data restricted to interactions from large-scale screens only (e.g. from the InWeb or, if possible, HINT database). The same bias may exist for the validation analysis focusing on the size of the largest connected component and the DIAMOnD analysis.

To address this concern in the revised manuscript, we have performed all three analyses (PPI, LCC, and DIAMOnD) on all four interactomes (the high-confidence interactome collected by Menche et al., 2015, InWeb_InBioMap, and both the binary and co-complex interactomes collected in the HINT database). Importantly, all of our conclusions remain unchanged regardless of which interaction database is used to perform the analysis, suggesting our results are not biased by artefacts of any interaction database.

We have revised the manuscript accordingly by adding several panels to the corresponding figure supplement (Figure 2---figure supplement 2).

> 2\) The authors should attempt to provide additional cell type specificity to the modules including M3 and M7 by using single cell RNA sequencing data from the spinal cord the following studies: a) www.biorxiv.org/content/early/2018/04/06/294918, b) Neuronal atlas of the dorsal horn defines its architecture and links sensory input to transcriptional cell types. Nature Neuroscience 2018; c) Massively Parallel Single Nucleus Transcriptional Profiling Defines Spinal Cord Neurons and Their Activity during Behavior, Cell 2018.

The availability of single-cell RNA-seq from the spinal cord provides an opportunity to replicate our analyses of module cell type specificity, derived from bulk RNA-seq of cultured or sorted cell populations, within in vivocell transcriptomes at the single-cell level. We analyzed the cell type specificity of our spinal cord modules within the recently published Zeisel et al. 2018, dataset at several different levels of cell type classification provided by the authors. Encouragingly, we found that at all three levels, the cell types inferred from single-cell RNA-seq matched perfectly to those inferred from the meta-analysis of bulk RNA-seq presented in the original manuscript, supporting the replicability of these results. In the revised manuscript, we include these analyses in a new supplementary figure, Figure 4---figure supplement 5.

We have revised the Results section accordingly as follows:

"To appreciate the cell type-specificity of each module, we additionally conducted a meta-analysis of transcriptomic and proteomic profiles from the major cell types of the CNS, incorporating both bulk and single-cell RNA-seq datasets (Zhang et al., 2014; Sharma et al., 2015; Cahoy et al., 2008; Zeisel et al., 2018) (Figure 4C and Figure 4---figure supplement 5)."

Unfortunately, we are unable to perform the same analysis for the Häring et al. (Nature Neuroscience2018) dataset or the Sathyamurthy et al. (Cell Reports2018) dataset. In the former case, all of the cells analyzed by the authors were neuronal cells, allowing the authors to define 30 neuronal subtypes in the dorsal horn. However, the statistical method we have used to analyze cell type-specific patterns of gene expression (pSI; Dougherty et al., 2010) tests whether genes are highly expressed in one cell type, relative to all other cell types. Because our coexpression network analysis identified a single prominent neuronal module, it is challenging to link results from bulk tissue to the neuronal subtypes at the resolution afforded by the Häring et al. study, by asking whether the neuronal module genes are more highly expressed in particular subtypes of neurons relative to other subtypes of neurons, and indeed this analysis did not produce interpretable results. In the latter case, the cell type annotations for the Sathyamurthy et al. dataset have not been made publicly available to accompany the raw expression data.

> B\) Request for deposit of material:
>
> The authors should put together a Github repository with all of the code used to perform the extensive analyses represented here. Given that the large majority of the work product here is in silico analysis of existing public resources, it seems only right for the authors to give back to the community so that each figure can be re-constructed from source code they make publicly-available. This is critical for reproducibility.

We are happy to make all the source code that was used to perform the analyses and produce the figures publicly available under an open-source, permissive license. We have released the source code as a GitHub repository, under the MIT license, at the following URL: [https://github.com/skinnider/spinal-cord-injury-*eLife*-2018]{.ul}. We hope that this step will allow others to reproduce and build on our work.

During the course of collecting this source code into a single repository for public distribution, we reproduced all of our analyses presented in the paper, and identified some minor inconsistencies with some of the P-values reported in the text. None of these changes materially affect our conclusions, or approach the threshold for statistical significance. However, we make note of these changes here for completeness.

We have revised the manuscript accordingly by adding a reference to the GitHub repository in the Materials and methods section:

"Code availability

The source code to reproduce all the analyses and generate the figures reported in this paper is available under the MIT license from https://github.com/skinnider/spinal-cord-injury-*eLife*-2018."

We have also updated the following P-values throughout the Results section:

1)In the section "Validation of literature-curated SCI genes":

"We therefore evaluated whether this same principle held for SCI by calculating the size of the largest connected component (LCC) between LC genes, and found that LC genes collectively formed a significantly larger subnetwork than random expectation (Figure 2E, empirical P \< 10^-3^), a finding that was again reproduced in independent interaction datasets (*P* \< 10^-3^, Figure 2---figure supplement 2D-F)."

2\) In the section "Gene coexpression network analysis of human spinal cord":

"Two modules, M3 and M7, were significantly enriched for LC genes (Fisher's exact test, Bonferroni-corrected *P* = 9.5 × 10^-8^ and 2.7 × 10^-3^, respectively)."

3\) In the section "Meta-analysis of coexpression network dysregulation in SCI":

"Among all seven modules, M2, M3, and M7 consistently showed the strongest evidence of differential expression (Figure 3F, *P* ≤ 6.5 × 10^-36^, 1.2 × 10^-48^, and 1.6 × 10^-14^, respectively)."

4\) In the section "Network analysis of SCI severity and recovery":

"This analysis revealed that the M3 eigengene was the most strongly correlated with injury severity (Spearman's ρ = 0.79, *P* = 2.5 × 10^-7^), with a clear separation in M3 expression between the mild, severe, and sham injury groups at 7 days post-injury (Figure 5E). \[...\] In rats treated with NT-3, known for its role in neuronal differentiation, axonal growth, and chemotropic guidance (Alto et al., 2009; Anderson et al., 2016), M9 was strongly upregulated at the lesion site relative to the experimental control (*P* = 9.3 × 10^-12^). Moreover, the M3 eigengene was significantly downregulated in NT-3-treated rats relative to controls (Figure 5K; one-tailed Wilcoxon rank-sum test, *P* = 2.1 × 10^-3^)."

> C\) Comments that may be addressed in the text:
>
> 1\) In genetics, less than 4% of the results from small-scale approaches (candidate gene analyses) have not been robustly replicated (Hirschhorn, Genetics in Medicine 2002). The authors should comment on: What are the potential reasons that a literature-seed gene approach seems to work well for SCI? What were the characters of the literature small-scale study approaches and experimental techniques that yielded the most predictive genes for the M3 and M7 networks -- any clear trends? Finally, were the M3 and M7 networks the top results in the RNA sequencing experiment, or were there WGCNA networks (or differentially expressed genes) stronger correlated with injury severity and functional recovery than the M3 and M7 networks, which would suggest additional relevant SCI pathways currently less well captured in literature?

With respect to the first question (why does our approach of literature curation work), our interpretation is that the issues that plague small-scale studies, including investigator biases, false positives, and false negatives, can be at least partially overcome by integrating the complete corpus of accumulated small-scale literature into an unbiased, genome-wide framework. In this respect, an analogy to the application of gene coexpression analysis to genetic diseases may be useful: while the true positive rate of de novomutation studies is almost certainly higher than 4%, any experimental technique to identify de novo mutations will inherently have nonzero false positive and false negative rates. The assumption made by gene coexpression analysis is that these false positives can be mitigated because they will largely contribute noise, whereas true positives will converge on common molecular processes that can be identified in an unbiased manner from genome-scale expression profiles. We have revised the Discussion to include some consideration of these points, as follows:

"In order to prioritize gene subnetworks, we conducted a systematic analysis of the SCI literature, and integrated genes implicated in the SCI response by small-scale experiments into our network analysis. \[...\] In the context of literature curation, as employed here, we posit that the relatively high false-positive rates of small-scale experiments, as well as their appreciable false-negative rates, can be mitigated by unbiased integration of data from small-scale experiments into a genome-wide framework."

With respect to the second question (what characteristics of small-scale experiments yield the most predictive genes for the M3 and M7 networks), we performed an additional analysis of which (a) analytical techniques, (b) experimental injury models, and (c) model organisms contributed the greatest proportions of LC genes to the M3 and M7 modules. In the revised manuscript, we include this analysis in an additional figure supplement, Figure 3---figure supplement 1.

We have revised the Results section of the manuscript accordingly as follows:

"We confirmed the robustness of the observed enrichment by randomly removing seed genes from the LC set, and by randomly adding false positive genes to the LC set. \[...\] Thus, M3 and M7 are robustly enriched for genes associated to the SCI response by small-scale studies, despite their divergent experimental designs."

Finally, with respect to the third question (were the M3 and M7 networks the top results in our RNA-seq experiment), there were no modules more strongly correlated with injury severity than M3 and M7, whose eigengenes were the first and second-most strongly correlated to injury severity respectively. However, two other modules (M1 and M14) were correlated to injury severity equally as strongly as M3. M1 was a highly reproducible, but somewhat human-specific module implicated by consensus in SCI and associated with oligodendrocyte function, whereas M14 was not associated with SCI and was not reproducible in the microarray dataset. In addition, one module (M6) was correlated equally as strongly as M7; M6 was a moderately reproducible, moderately conserved 'consensus' SCI module involved in cellular protein modification. Overall, this suggests that our network signature of SCI (Figure 5B) captures the critical severity-dependent pathways activated by experimental SCI.

> 2\) The literature curated genes coalesce on common biological functions that depends on them being accurately annotated. Could the author comment if there is bias towards literature genes even if genes have to be annotated to at least three Gene Ontology terms?

Like any enrichment analyses involving the Gene Ontology, our validation approach to literature-curated SCI genes makes the implicit assumption that these genes are accurately annotated within the GO. In fact, however, we found that LC genes were associated with *fewer* GO terms than the proteome average (Wilcoxon rank-sum test, P \< 10^-15^). Our initial requirement that LC genes be annotated to at least three GO terms to be carried forward in the GO enrichment analysis was an attempt to control for this effect, based on literature precedent (Hein et al., 2015). However, in the revised manuscript, we have redone the analysis without this requirement. We find that, although the magnitude of the enrichment is slightly decreased, our essential findings remain unchanged: LC genes are strongly and significantly enriched for shared GO terms relative to random sets of genes, implying the LC genes converge on common biological functions.

We have revised the manuscript accordingly by replacing Figure 2C, and by removing references to this requirement in the Materials and methods, as follows:

"GO terms were retrieved from the UniProt-GOA database (Dimmer et al., 2012). We compared the number of shared GO terms within each ontological category at three breadth cutoffs between all pairs of literature-curated genes to the number of shared GO terms between random sets of genes."

> 3\) The authors should mention that the assumption underlying their work is that gene expression data in control individuals is indicative of processes dysregulated in SCI. Even so this assumption seems to hold true in their case it remains to be shown whether it holds true in general.

We agree that the assumption that the organization of the spinal cord transcriptome in healthy human subjects is informative about the processes dysregulated in SCI is a fundamental assumption of our approach. Given the impracticality of obtaining spinal cord parenchymal tissue from human patients, this seemed to us a reasonable assumption to make, and one that was subsequently validated by the analyses presented in the paper. However, we acknowledge that this is a potential limitation of applying gene coexpression analysis to acquired or traumatic conditions using our literature curation framework more generally. We revised the Discussion accordingly to highlight this limitation, as follows:

"Importantly, this experimental design provides an approach to extend gene coexpression network analysis to acquired and traumatic conditions, using samples from healthy tissues. \[...\] Although the analyses presented here indicate that this assumption appears to be valid in the case of SCI, future work will be needed to establish whether this principle holds in general."

> 4\) As most inflammatory mediators are expressed at low levels in the uninjured spinal cord, and the subsequent increase in expression is a response to injury, they are likely to correlate with SCI severity. It may therefore be suspected to find a M3 module enriched for markers of microglia positively that correlate positively with injury severity. The authors could have consider to expand the significance of their work by including additional analysis from another publicly available dataset where a different strategy was shown to promote functional recovery after SCI. In absence of this analysis the authors should discuss the general predictivity of their analysis with respect to the different modules.

To address this comment, we analyzed an additional, recently described dataset (Anderson et al., 2016), in which the authors found that knockout of STAT3 was associated with increased axonal dieback following experimental SCI. The authors performed RNA-seq of immunoprecipitated astrocytes and non-astrocytes (flow-through) separately. We re-analyzed the flow-through fraction, comparing wild-type mice to STAT3 knockout mice, and found that the resulting signature perfectly recapitulated our consensus network signature of SCI. Indeed, the WT vs. STAT3 KO signature represents the exact opposite to the severity-dependent injury signature revealed by our own RNA-sequencing experiment. Thus, we are able to independently validate our signature in a dramatically different experimental context (i.e., inhibition of astrocytic scar formation), supporting the notion that it has a general predictivity.

We have revised the manuscript accordingly by updating Figure 5B, to include the results comparing astrocyte scar formation to prevention of scarring.

In addition, we have updated the final paragraph of the Results section to include this additional comparison, as follows:

"Given the strong relationship between injury severity and M3 expression, we hypothesized that targeting the transcriptional profile of this module could represent a viable strategy for development of novel therapies for SCI. \[...\] These results indicate that reversal of the transcriptome changes observed in response to SCI is associated with functional recovery and decreased axonal dieback in rodent models, and highlight M3 expression as a predictor of functional recovery."

[^1]: These authors contributed equally to this work.
